These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2917676)

  • 1. Influence of topically applied betamethasone-17-valerate on cell cycle kinetics of human anagen hair determined by DNA flow cytometry.
    Schell H; Kiesewetter F; Pausch C; Arai A; Katsuoka K; Hornstein OP
    Dermatologica; 1989; 178(1):12-5. PubMed ID: 2917676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA impulse cytophotometric studies of the modification of the proliferation behavior of the outer hair root sheath by topical glucocorticoid administration].
    Schell H; Kiesewetter F; Pausch C; Arai A
    Z Hautkr; 1988 Jun; 63(6):505-8. PubMed ID: 3407265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proliferation behavior of the anagen hair bulb in androgenetic alopecia before and after local administration of 17 alpha- propylmesterolone--DNA flow cytophotometry studies].
    Kiesewetter F; Schell H; Seidel C; von Hintzenstern J
    Z Hautkr; 1990 Dec; 65(12):1115-9. PubMed ID: 2087839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evaluation of a new topical preparation containing dextran sulphate and betamethasone 17-valerate.
    Passarella E; Milanino R
    Arzneimittelforschung; 1980; 30(4):647-51. PubMed ID: 6156688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application.
    Bromley PA; Müller FO; Malan J; Torres J; Vanderbeke O
    S Afr Med J; 1978 Aug; 54(6):239-41. PubMed ID: 362568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hair growth promoters in androgenetic alopecia. Expectations and reality].
    Schell H; Kiesewetter F; Hornstein OP
    Hautarzt; 1994 Jun; 45(6):360-3. PubMed ID: 8071065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle kinetics of human anagen scalp hair bulbs in thyroid disorders determined by DNA flow cytometry.
    Schell H; Kiesewetter F; Seidel C; von Hintzenstern J
    Dermatologica; 1991; 182(1):23-6. PubMed ID: 1901552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell kinetics of human scalp hair--impulse cytophotometric studies].
    Deinlein E; Schell H; Rodehorst R; Katsuoka K
    Z Hautkr; 1986 Aug; 61(16):1137-44. PubMed ID: 3765760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical treatment with desoxymethasone solution 0.25% with salicylic acid 1% and betamethasone valerate solution 0.1% in patients with psoriasis of the scalp.
    Hillström L
    J Int Med Res; 1984; 12(3):170-3. PubMed ID: 6734919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of some variables affecting the blanching activity of betamethasone 17-valerate cream.
    Magnus AD; Haigh JM; Kanfer I
    Dermatologica; 1980; 160(5):321-7. PubMed ID: 7364141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intralesional Triamcinolone Acetonide Versus Topical Betamethasone Valearate in the Management of Localized Alopecia Areata.
    Devi M; Rashid A; Ghafoor R
    J Coll Physicians Surg Pak; 2015 Dec; 25(12):860-2. PubMed ID: 26691357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.
    El-Ashmawy AA; El-Maadawy IH; El-Maghraby GM
    J Dermatolog Treat; 2018 Feb; 29(1):55-64. PubMed ID: 28521549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of betamethasone after topical application of betamethasone 17-valerate: comparison with oral administration.
    Kubota K; Lo ES; Huttinot G; Andersen PH; Maibach HI
    Br J Clin Pharmacol; 1994 Jan; 37(1):86-8. PubMed ID: 8148226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell kinetics of anagen scalp hairs under physiological and pathological conditions.
    Kiesewetter F; Schell H
    Skin Pharmacol; 1994; 7(1-2):55-60. PubMed ID: 8003324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical betamethasone-17-valerate inhibits heat-induced vasodilatation in man.
    Ahluwalia A; Flower RJ
    Br J Dermatol; 1993 Jan; 128(1):45-8. PubMed ID: 8427821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
    Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H
    J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect on adrenal axis function of topically applied betamethasone valerate ointment 0.1%.
    Fischer GO
    Australas J Dermatol; 1983 Apr; 24(1):26-32. PubMed ID: 6312951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.